News

The Perlegen intellectual property includes gene variants on chromosome 9p21 linked to increased risk of cardiovascular disease, especially in diabetic patients with poor glycemic control. The licensing agreement

According to ALR Technologies, the ALRT Health-E-Connect system is a communication tool for patients to provide ongoing diagnostic and adherence data to their physicians. Information provided by the

Maryland-based company Sanaria, with support from the PATH Malaria Vaccine Initiative, has initiated a Phase I clinical trial of its malaria vaccine candidate. Unlike other malaria vaccine candidates,

According to Quick-Med Technologies, Nimbus is a next-generation antimicrobial technology that is non-leaching, non-toxic, long-lasting and not blocked by organics such as blood, urine and perspiration. Ladd Greeno,

According to ApaTech, the results from three new studies show that Actifuse has the potential to be as clinically effective as ICBG, without the problems associated with the

BioFocus DPI will utilize Cellectricon’s DynaflowHT, a fully automated patch clamp (APC) system, to further increase its electrophysiology-based screening capacity, particularly for fast ligand-gated ion channels, said Cellectricon.

Tranzyme Pharma has reported that its potent and selective ghrelin agonist, TZP-101, demonstrated effectiveness in the treatment of gastroparesis, an inability of the stomach to empty food efficiently,

The Sapphire study will be carried out in Europe, America and Asia. Approximately 70 hospital centers will participate. The Phase III study is designed as a randomized, active-controlled,

Ethicon Endo-Surgery, a Johnson & Johnson company, has received the FDA’s approval for the company’s investigational device exemption application to conduct the study of devices designed for use